Advanced Search
Cooperative Effects of Monkshood Polysaccharide with Adriamycin Magnetic Albumin Microsphere Targeting Therapy on Tumor[J]. Journal of China Pharmaceutical University, 2003, (6): 68-72.
Citation: Cooperative Effects of Monkshood Polysaccharide with Adriamycin Magnetic Albumin Microsphere Targeting Therapy on Tumor[J]. Journal of China Pharmaceutical University, 2003, (6): 68-72.

Cooperative Effects of Monkshood Polysaccharide with Adriamycin Magnetic Albumin Microsphere Targeting Therapy on Tumor

More Information
  • AIM: To observe the cooperative inhi bitor y effects of monkshood polysaccharide (MPS) with adriamycin magnetic albumin mic rosphere (ADM-MAM) targeting therapy on tumor and to study the antitumor mecha n ism. METHOD: The antitumor activity was observed u
  • Related Articles

    [1]HOU Kai, LI Ping, ZHANG Jinlian, WANG Fang, YANG Yu. Blood coagulation factor XI: new strategy of targeted anticoagulant therapy[J]. Journal of China Pharmaceutical University, 2024, 55(5): 708-714. DOI: 10.11665/j.issn.1000-5048.2023050101
    [2]CUI Huayuan, YAO Dan, WANG Yuxiang, HU Yiqiao. Novel nano-scaled Mn-metal-organic framework for enhancing photodynamic therapy through overcoming tumor hypoxia[J]. Journal of China Pharmaceutical University, 2019, 50(6): 678-685. DOI: 10.11665/j.issn.1000-5048.20190607
    [3]YUE Yali, YIN Jun, GAO Xiangdong, YAO Wenbing. Research advances of bispecific antibody drugs in tumor therapy[J]. Journal of China Pharmaceutical University, 2019, 50(3): 289-298. DOI: 10.11665/j.issn.1000-5048.20190304
    [4]CAI Han, LIU Yanhong, YIN Tingjie, ZHOU Jianping, HUO Meirong. Advances in the targeted therapy of tumor-associated fibroblasts[J]. Journal of China Pharmaceutical University, 2018, 49(1): 20-25. DOI: 10.11665/j.issn.1000-5048.20180103
    [5]ZHAO Yuekui, TANG Shanshan, ZHANG Yanfeng, ZONG Li, JIN Liang. Engineered mesenchymal stem cells as targeting therapeutic carriers in cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(2): 134-139. DOI: 10.11665/j.issn.1000-5048.20160202
    [6]PAN Jiajia, JIA Xiaoqing, HUANG Gang, ZHANG Yubin. PD-1/PD-Ls signaling pathway and the application of anti-PD-1/PD-Ls antibodies in cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(1): 9-18. DOI: 10.11665/j.issn.1000-5048.20160102
    [7]JIN Hui, LIU Lifeng, DENG Weiping, LIU Jianwen. Antitumor effects and molecular mechanisms of novel selective HDAC inhibitors in human cervix carcinoma HeLa cells[J]. Journal of China Pharmaceutical University, 2013, 44(4): 352-356. DOI: 10.11665/j.issn.1000-5048.20130413
    [8]Transcription factors as new targets for cancer therapy[J]. Journal of China Pharmaceutical University, 2010, 41(2): 97-103.
    [9]Tumor microenvironment:A novel target for antitumor activity of polysaccharides[J]. Journal of China Pharmaceutical University, 2010, 41(1): 1-10.
    [10]Research Advances in the Targeting of Epidermal Growth Factor Receptor[J]. Journal of China Pharmaceutical University, 2004, (3): 91-94.

Catalog

    Article views (873) PDF downloads (706) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return